The Anticonconvulsant Drug Development program at the University of Utah has been instrumental in bringing an amazing 16 epilepsy drugs to the market. Director H. Steve White, Ph.D., describes the program, the reasons behind its success, new directions in epilepsy treatment. In a separate Scope interview, Dr. White describes his personal connection to the disease and how it has motivated his work.
- Tags
-